Imunon, Inc. (IMNN)
1.475
+0.02
(+1.72%)
USD |
NASDAQ |
Sep 11, 13:46
Imunon Gross Profit (TTM) : -0.6718M for June 30, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.6718M |
| March 31, 2026 | -0.6675M |
| December 31, 2025 | -0.6989M |
| September 30, 2025 | -0.6949M |
| June 30, 2025 | -0.7171M |
| March 31, 2025 | -0.7377M |
| December 31, 2024 | -0.7181M |
| September 30, 2024 | -0.6934M |
| June 30, 2024 | -0.7024M |
| March 31, 2024 | -0.5172M |
| December 31, 2023 | -0.5315M |
| September 30, 2023 | -0.484M |
| June 30, 2023 | -0.3324M |
| March 31, 2023 | -0.3753M |
| December 31, 2022 | -0.2316M |
| September 30, 2022 | -0.1737M |
| June 30, 2022 | -0.1271M |
| March 31, 2022 | -0.0842M |
| December 31, 2021 | -0.0352M |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Phio Pharmaceuticals Corp. | -0.005M |
| Agenus, Inc. | 127.32M |
| Amgen, Inc. | 27.78B |
| Anika Therapeutics, Inc. | 75.00M |
| BioCryst Pharmaceuticals, Inc. | 917.38M |